Evaluation of psychosocial functioning in the acute treatment term of major depressive disorder: A 16-week multi-centered follow-up study

• Published in: Asian journal of psychiatry 2021-12, Vol.66, p.102883-102883, Article 102883
• Main Authors: Altunsoy, Neslihan, Di̇ki̇ci̇, Didem Sücüllüoğlu, Çökmüş, Fikret Poyraz, Özkan, Hüseyin Murat, Aşçibaşi, Kadir, Alçi, Deniz, Kuru, Erkan, Yüzeren, Serra, Aydemi̇r, Ömer
• Format: Article
• Language: English
• Subjects: Antidepressive agents; Depression; Depressive disorder; Psychosocial functioning; Quality of life
• ISSN: 1876-2018; 1876-2026
• DOI: 10.1016/j.ajp.2021.102883

Major depressive disorder is the leading cause of non-fatal burden, and disability in adulthood. Even though depression is well-treated in the acute term,psychosocial functioning does not get back to the premorbid level most of the time. In this present study, it is aimed to evaluate the outcome of the acute term treatment of major depressive disorder in terms of psychosocial functioning. The study is an open-label, observational, multi-center follow-up study for four months of patients with major depressive disorder according to DSM-5. Patients were evaluated with Montgomery Asberg Depression Rating Scale (MADRS), Sheehan Disability Scale (SDS) and Short Form-36 (SF-36) at the beginning, and at the 2., 4., 8., 12. and 16.weeks. 100 patients were invited to the study and 56 patients completed the study.As a result of the treatment, the mean MADRS and SDS scores decreased significantly. All domains of SF-36 were improved significantly with the treatment. Unfortunately patients suffering from MDD could not reach the normative data,especially on the domains of social functioning, role emotional, pain, and general health perception. Treatment outcomes show that SNRI users presented higher scores on the domains of pain and physical functioning. However SSRI users showed better outcomes on the domains of mental health and vitality. Our research corroborated that even patients gain symptomatic remission in MDD treatment, psychosocial dysfunction persists. It is also concluded that different antidepressant options may act differently on treatment outcomes. •Even patients gain symptomatic remission in major depressive disorder(MDD) treatment, psychosocial dysfunction persists.•After treatment, patients suffering from MDD could not reach the normative data in terms of psychosocial functioning.•Different antidepressant options may act differently on treatment outcomes.•Treatment outcomes show that SNRI users presented higher scores on the domains of pain and physical functioning.•SSRI users showed better outcomes on the domains of mental health and vitality.